Drug Profile
UB 211
Alternative Names: Anti-IgE allergy vaccine - United Biomedical; UB-211Latest Information Update: 28 Oct 2019
Price :
$50
*
At a glance
- Originator United Biomedical
- Class Allergy immunotherapies; Antiallergics
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Allergic rhinitis
- No development reported Asthma; Hypersensitivity
Most Recent Events
- 28 Oct 2019 No recent reports of development identified for phase-I development in Allergy in USA
- 25 Sep 2019 Preclinical trials in Allergic rhinitis in USA, before September 2019 (unspecified route)
- 25 Sep 2019 Taiwan Food and Drug Administration accepts IND for UB 211 for Allergic rhinitis for review